Unicycive Therapeutics, Inc. (UNCY)

NASDAQ: UNCY · Real-Time Price · USD

5.05

-0.15 (-2.88%)

At close: Sep 1, 2026, 4:00 PM EDT

5.10

+0.05 (0.99%)

Pre-market: Sep 2, 2026, 7:05 AM EDT

Unicycive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	44.19	29.2	26.14	9.7	0.46	16.58
Short-Term Investments	17.24	12.07	-	-	-	-
Cash & Short-Term Investments	61.43	41.27	26.14	9.7	0.46	16.58
Cash Growth	175.12%	57.87%	169.48%	2032.09%	-97.26%	-
Prepaid Expenses	7.63	6.52	3.87	3.37	2.03	1.71
Other Current Assets	2.27	1.17	0.94	0.33	0.16	0.13
Total Current Assets	71.32	48.96	30.95	13.4	2.64	18.41
Property, Plant & Equipment	0.71	0.17	0.72	0.79	0.17	0.33
Total Assets	72.03	49.14	31.67	14.19	2.82	18.74

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.23	0.38	1.06	0.84	0.89	0.74
Accrued Expenses	2.14	1.52	3.56	3.23	2.24	1.21
Current Portion of Leases	0.62	0.12	0.56	0.33	0.16	0.15
Other Current Liabilities	13.72	16.92	18.94	13.13	-	-
Total Current Liabilities	18.7	18.94	24.12	17.53	3.28	2.11
Long-Term Leases	0.06	-	0.12	0.47	-	0.16
Total Liabilities	18.76	18.94	24.24	18	3.28	2.26

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.03	0.02	0.01	0.04	0.02	0.02
Additional Paid-In Capital	195.64	158	108.69	60.7	33.52	32.41
Retained Earnings	-142.37	-127.83	-101.27	-64.54	-34	-15.94
Comprehensive Income & Other	-0.02	-0	-	-	-	-
Shareholders' Equity	53.27	30.2	7.43	-3.81	-0.47	16.48
Total Liabilities & Equity	72.03	49.14	31.67	14.19	2.82	18.74

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.67	0.12	0.68	0.79	0.16	0.31
Net Cash (Debt)	60.75	41.15	25.46	8.91	0.3	16.27
Net Cash Growth	177.19%	61.63%	185.82%	2869.33%	-98.16%	-
Net Cash Per Share	2.69	2.59	3.80	3.63	0.20	13.94
Filing Date Shares Outstanding	27.86	25.24	11.97	3.48	1.52	1.5
Total Common Shares Outstanding	27.86	22.11	11.38	3.48	1.52	1.5
Working Capital	52.62	30.02	6.83	-4.14	-0.64	16.31
Book Value Per Share	1.91	1.37	0.65	-1.10	-0.31	10.99
Tangible Book Value	53.27	30.2	7.43	-3.81	-0.47	16.48
Tangible Book Value Per Share	1.91	1.37	0.65	-1.10	-0.31	10.99
Machinery	0.07	0.07	0.07	0.02	0.01	0.01
Leasehold Improvements	0.04	0.07	0.05	0.02	0.02	0.02

SEC Filings: 10-K · 10-Q